David R. Ghasemi

MYCN amplification drives an aggressive form of spinal ependymoma

David R. Ghasemi, Martin Sill, Konstantin Okonechnikov et al. · Acta Neuropathologica · 2019 · 178 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion–Positive Supratentorial Ependymomas

Tuyu Zheng, David R. Ghasemi, Konstantin Okonechnikov et al. · Cancer Discovery · 2021 · 110 citations · Full text

Medicine, Cancer Biology, Oncology +16

Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

Philipp Sievers, Sophie C. Henneken, Christina Blume et al. · Acta Neuropathologica · 2021 · 79 citations · Full text

Medicine, Genetics, Oncology +12

Developmental basis of SHH medulloblastoma heterogeneity

Maxwell P. Gold, Winnie Ong, Andrew M. Masteller et al. · Nature Communications · 2024 · 29 citations · Full text

Medicine, Developmental Biology, Oncology +17

Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas

Margaret Shatara, Kathleen M. Schieffer, Darren Klawinski et al. · Acta Neuropathologica Communications · 2021 · 24 citations · Full text

Medicine, Oncology, Pathology +16